Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)
China
· Delayed Price · Currency is CNY 5.47
-0.04 (-0.73%)
Feb 21, 2025, 3:04 PM CST
SHE:002550 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 20, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 6,836 | 7,525 | 8,012 | 6,181 | 5,439 | 5,862 | Upgrade
|
| Market Cap Growth | 13.37% | -6.07% | 29.61% | 13.64% | -7.21% | 20.52% | Upgrade
|
| Enterprise Value | 6,159 | 7,054 | 7,508 | 5,582 | 4,818 | 5,829 | Upgrade
|
| Last Close Price | 5.47 | 5.76 | 6.00 | 4.53 | 3.87 | 3.94 | Upgrade
|
| PE Ratio | 23.86 | 41.38 | 24.77 | 34.14 | - | 22.33 | Upgrade
|
| Forward PE | 19.77 | 20.00 | 20.00 | 20.00 | 20.00 | 20.13 | Upgrade
|
| PS Ratio | 4.50 | 4.15 | 3.48 | 3.30 | 3.26 | 3.50 | Upgrade
|
| PB Ratio | 2.76 | 3.04 | 3.29 | 2.92 | 2.63 | 2.51 | Upgrade
|
| P/TBV Ratio | 3.22 | 3.23 | 3.43 | 3.08 | 2.78 | 2.66 | Upgrade
|
| P/FCF Ratio | 13.53 | 17.38 | - | 468.80 | 21.35 | 96.31 | Upgrade
|
| P/OCF Ratio | 12.77 | 14.11 | - | 59.69 | 17.14 | 36.29 | Upgrade
|
| EV/Sales Ratio | 3.96 | 3.89 | 3.26 | 2.98 | 2.89 | 3.48 | Upgrade
|
| EV/EBITDA Ratio | 16.25 | 31.86 | 26.13 | 25.17 | 17.19 | 19.21 | Upgrade
|
| EV/EBIT Ratio | 19.87 | 45.73 | 33.73 | 36.63 | 22.94 | 24.49 | Upgrade
|
| EV/FCF Ratio | 12.19 | 16.29 | - | 423.36 | 18.91 | 95.77 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.02 | 0.04 | 0.04 | 0.02 | 0.15 | Upgrade
|
| Debt / EBITDA Ratio | 0.05 | 0.25 | 0.36 | 0.42 | 0.15 | 1.13 | Upgrade
|
| Debt / FCF Ratio | 0.04 | 0.13 | - | 7.10 | 0.16 | 5.66 | Upgrade
|
| Asset Turnover | 0.57 | 0.65 | 0.87 | 0.76 | 0.62 | 0.55 | Upgrade
|
| Inventory Turnover | 1.43 | 1.84 | 3.03 | 2.92 | 3.13 | 3.57 | Upgrade
|
| Quick Ratio | 5.46 | 4.89 | 4.00 | 3.83 | 4.18 | 3.35 | Upgrade
|
| Current Ratio | 8.32 | 7.90 | 6.06 | 5.30 | 5.35 | 3.85 | Upgrade
|
| Return on Equity (ROE) | 11.67% | 7.28% | 14.06% | 8.91% | -6.71% | 10.55% | Upgrade
|
| Return on Assets (ROA) | 7.04% | 3.46% | 5.23% | 3.84% | 4.87% | 4.87% | Upgrade
|
| Return on Capital (ROIC) | 7.74% | 3.81% | 5.86% | 4.41% | 5.49% | 5.27% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.03% | 6.03% | 8.80% | 6.89% | 9.72% | 9.95% | Upgrade
|
| Earnings Yield | 4.29% | 2.42% | 4.04% | 2.93% | -2.43% | 4.48% | Upgrade
|
| FCF Yield | 7.39% | 5.75% | -1.78% | 0.21% | 4.68% | 1.04% | Upgrade
|
| Dividend Yield | 2.19% | 2.08% | 2.00% | 2.65% | 3.10% | 6.35% | Upgrade
|
| Payout Ratio | 51.74% | 87.31% | 47.97% | 83.67% | - | 64.80% | Upgrade
|
| Buyback Yield / Dilution | 2.38% | -0.41% | -7.16% | -0.58% | 4.01% | 3.98% | Upgrade
|
| Total Shareholder Return | 4.57% | 1.67% | -5.16% | 2.07% | 7.11% | 10.32% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.